Pharmaceutical compositions

Details for Australian Patent Application No. 2009281223 (hide)

Owner Novartis AG

Inventors Schonhammer, Karin

Agent Davies Collison Cave

Pub. Number AU-A-2009281223

PCT Pub. Number WO2010/018159

Priority 09151917.3 03.02.09 EP; 08165662.1 01.10.08 EP; 08162213.6 12.08.08 EP

Filing date 11 August 2009

Wipo publication date 18 February 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/31 (2006.01) Medicinal preparations containing peptides - Somatostatins

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/018159 Priority application(s): WO2010/018159

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009281242-Surface covering with static control properties

2009281218-Processes for the preparation of 4-oxo-octahydro -indole-1-carbocylic acid methyl ester and derivatives thereof